Instituto Universitario de of talmobiologia Aplicada
Midwest Eye-Banks
Baqiyatallah Medical Sciences University
Stavanger University Hospital
Shiraz University of Medical Sciences
University of Leipzig
5件の主要臨床プロファイル
付録
図表一覧
※ このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。
目次
Abstract
Retinal Vein Occlusion Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, "Retinal Vein Occlusion Global Clinical Trials Review, H1, 2013" provides data on the Retinal Vein Occlusion clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Retinal Vein Occlusion. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Retinal Vein Occlusion. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
TOC
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Retinal Vein Occlusion 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Retinal Vein Occlusion 24
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Retinal Vein Occlusion Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Allergan, Inc. 33
Clinical Trial Overview of Allergan, Inc. 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Genentech, Inc. 35
Clinical Trial Overview of Genentech, Inc. 35
Novartis Pharmaceuticals Corporation 36
Clinical Trial Overview of Novartis Pharmaceuticals Corporation 36
Regeneron Pharmaceuticals, Inc. 37
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 37
Mid Atlantic Retina 38
Clinical Trial Overview of Mid Atlantic Retina 38
Chengdu Kanghong Pharmaceuticals Group Co., Ltd. 39
Clinical Trial Overview of Chengdu Kanghong Pharmaceuticals Group Co., Ltd. 39
Aleris Helse AS 40
Clinical Trial Overview of Aleris Helse AS 40
Opocrin S.p.A 41
Clinical Trial Overview of Opocrin S.p.A 41
Retina Associates of Cleveland, Inc. 42
Clinical Trial Overview of Retina Associates of Cleveland, Inc. 42
Icon Bioscience, Inc. 43
Clinical Trial Overview of Icon Bioscience, Inc. 43
The EMMES Corporation 44
Clinical Trial Overview of The EMMES Corporation 44
Alimera Sciences, Inc. 45
Clinical Trial Overview of Alimera Sciences, Inc. 45
ARCA biopharma, Inc. 46
Clinical Trial Overview of ARCA biopharma, Inc. 46
Fovea Pharmaceuticals SA 47
Clinical Trial Overview of Fovea Pharmaceuticals SA 47
Sanwa Kagaku Kenkyusho Co., Ltd. 48
Clinical Trial Overview of Sanwa Kagaku Kenkyusho Co., Ltd. 48
Bayer AG 49
Clinical Trial Overview of Bayer AG 49
Santen Pharmaceutical Co., Ltd. 50
Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 50
Eyetech Pharmaceuticals, Inc. 51
Clinical Trial Overview of Eyetech Pharmaceuticals, Inc. 51
Valeant Pharmaceuticals International, Inc. 52
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 52
Clinical Trial Overview of Top Universities / Institutes / Hospitals 53
Shaheed Beheshti Medical University 53
Clinical Trial Overview of Shaheed Beheshti Medical University 53
Kyoto University 54
Clinical Trial Overview of Kyoto University 54
Johns Hopkins University 55
Clinical Trial Overview of Johns Hopkins University 55
University of Toronto 56
Clinical Trial Overview of University of Toronto 56
Barnes Retina Institute 57
Clinical Trial Overview of Barnes Retina Institute 57
S:t Eriks Ogonsjukhus AB 58
Clinical Trial Overview of S:t Eriks Ogonsjukhus AB 58
Shiga University of Medical Science 59
Clinical Trial Overview of Shiga University of Medical Science 59
Duke University 60
Clinical Trial Overview of Duke University 60
Medical University of Vienna 61
Clinical Trial Overview of Medical University of Vienna 61
Ludwig-Maximilians-Universitat Munich 62
Clinical Trial Overview of Ludwig-Maximilians-Universitat Munich 62
California Retina Consultants 63
Clinical Trial Overview of California Retina Consultants 63
Asociacion para Evitar la Ceguera en Mexico I.A.P. 64
Clinical Trial Overview of Asociacion para Evitar la Ceguera en Mexico I.A.P. 64
